Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

96.30
Delayed Data
As of Dec 12
 -0.17 / -0.18%
Today’s Change
59.27
Today|||52-Week Range
98.52
+53.78%
Year-to-Date

Today’s Trading

Previous close96.47
Today’s open96.62
Day’s range94.76 - 96.69
Volume4,195,218
Average volume (3 months)6,095,851
Market cap$153.8B
Data as of 4:00pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+15.21%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+12.16%
P/E ratio23.4
Price/Sales3.98
Price/Book33.14

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.26+0.59%
CELGCelgene+1.04+0.96%
BMYBristol-Myers Squibb+0.26+0.41%
GSKGlaxoSmithKline+0.21+0.59%
Data as of 4:02pm ET, 12/12/2017

Financials

Next reporting dateFebruary 2, 2018
EPS forecast (this quarter)$1.44
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts